Cisatracurium Besilate

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0096946-42-8

Chemical Formula

C65-H82-N2-O18-S2

Molecular Weight

1243

Therapeutic Category

Muscle relaxant, peripherally acting

Chemical Name

Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate, [1R-[1α,2α(1'R*,2'R*)]]-

Foreign Names

• Cisatracurii besilas (Latin)
• Cisatracurium-Kation (German)
• Besilate de cisatracurium (French)
• Besilato de cisatracurio (Spanish)

Generic Names

• Cisatracurium Besilate (OS: BAN)
• Cisatracurium Besylate (OS: USAN)
• 51W89 (IS: GlaxoWellcome)

Brand Names

• Nimbex
  Abbott, Canada; Abbott, United States; Glaxo SmithKline, Spain; Glaxo Wellcome, Portugal; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Netherlands Antilles; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Barbados; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Egypt; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Grenada; GlaxoSmithKline, Greece; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Honduras; GlaxoSmithKline, Hungary; GlaxoSmithKline, Iraq; GlaxoSmithKline, Iran; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Jordan; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Panama; GlaxoSmithKline, Poland; GlaxoSmithKline, Qatar; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Saudi Arabia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Slovenia; GlaxoSmithKline, El Salvador; GlaxoSmithKline, Syria; GlaxoSmithKline, Thailand; GlaxoSmithKline, Tunisia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Yemen; GlaxoSmithKline, South Africa; Wellcome-GB, Italy



• Nimbex (veterinary use)
  GlaxoSmithKline, United Kingdom



• Nimbium
  GlaxoSmithKline, Argentina; GlaxoSmithKline, Brazil

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.